ADVISORY-Ignore incorrect advisory alert on Beyond Cancer coding error

Reuters
2024-12-04
ADVISORY-Ignore incorrect advisory alert on Beyond Cancer coding error

An incorrect advisory alert saying Beyond Cancer's clinical trial approval was wrongly tagged to Beyond Air XAIR.O has been withdrawn.

Beyond Cancer is a unit of biopharma company Beyond Air, and the original alert from Beyond Cancer's press release was correctly coded.

For the correctly coded alert on Beyond Cancer's clinical trial approval, click nFWN3N415S

STORY_NUMBER: nFWN3N410N

STORY_DATE: 03/12/2024

STORY_TIME: 09:14:12 PM GMT

((bangalore.newsroom@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10